Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or CabozantinibRoberto Iacovelli, Giuseppe Procopio, Marco Maruzzo et al.|Clinical Genitourinary Cancer|2022Cited by 9